124 related articles for article (PubMed ID: 2391694)
1. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine](sulfato)platinum-(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties.
Gust R; Burgemeister T; Mannschreck A; Schönenberger H
J Med Chem; 1990 Sep; 33(9):2535-44. PubMed ID: 2391694
[TBL] [Abstract][Full Text] [Related]
2. [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.
Gust R; Faderl M; Schönenberger H
J Cancer Res Clin Oncol; 2000 Nov; 126(11):647-54. PubMed ID: 11079729
[TBL] [Abstract][Full Text] [Related]
3. Third generation antitumor platinum(II) complexes of the [1-(fluoro/difluorophenyl)-2-phenylethylenediamine]platinum(II) type.
Gust R; Schönenberger H
Arch Pharm (Weinheim); 1995; 328(7-8):595-603. PubMed ID: 7492264
[TBL] [Abstract][Full Text] [Related]
4. Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2- phenylethylenediamine]sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring, II: Correlation of molecular structure and estrogenic activity of breast and prostate cancer inhibiting. [erythro-1-(2,6-dichloro-4-hydroxyphenyl)-2-(2-halo-4- hydroxyphenyl)ethylenediamine]platinum(II) complexes.
Gust R; Schönenberger H; Klement U; Range KJ
Arch Pharm (Weinheim); 1993 Dec; 326(12):967-76. PubMed ID: 8122966
[TBL] [Abstract][Full Text] [Related]
5. Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]- sulfatoplatinum(II), a new compound for the treatment of the mammary carcinoma.
Gust R
Arch Pharm (Weinheim); 1994 Jan; 327(1):49-54. PubMed ID: 8117188
[TBL] [Abstract][Full Text] [Related]
6. 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
Schertl S; Hartmann RW; Batzl-Hartmann C; Schlemmer R; Spruss T; Bernhardt G; Gust R; Schönenberger H
Arch Pharm (Weinheim); 2001 Apr; 334(4):125-37. PubMed ID: 11382148
[TBL] [Abstract][Full Text] [Related]
7. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines.
Kratochwil NA; Bednarski PJ
Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538
[TBL] [Abstract][Full Text] [Related]
8. Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes.
Gust R; Schönenberger H
Arch Pharm (Weinheim); 1993 Jul; 326(7):405-13. PubMed ID: 8357303
[TBL] [Abstract][Full Text] [Related]
9. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
10. Tumor inhibiting [1,2-bis(difluorophenyl)ethylenediamine]dichloroplatinum (II) complexes, I: Synthesis.
Müller R; Schickaneder E; Jennerwein M; Reile H; Spruss T; Engel J; Schönenberger H
Arch Pharm (Weinheim); 1991 Feb; 324(2):115-20. PubMed ID: 1854235
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the configurational and conformational influences on the hormonal activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes. 1. Synthesis, estradiol receptor affinity, and estrogenic activity of diastereomeric [N-alkyl- and N,N'-dialkyl-1,2- bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes.
Gust R; Niebler K; Schönenberger H
J Med Chem; 1995 Jun; 38(12):2070-9. PubMed ID: 7783138
[TBL] [Abstract][Full Text] [Related]
12. Unsymmetrical C-substituted ethylenediamine platinum coordination complexes: synthesis and activity against mouse leukemia L1210.
Hall LM; Speer RJ; Ridgway HJ; Norton SJ
J Inorg Biochem; 1979 Oct; 11(2):139-49. PubMed ID: 501351
[TBL] [Abstract][Full Text] [Related]
13. Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes.
Jennerwein M; Wappes B; Gust R; Schönenberger H; Engel J; Seeber S; Osieka R
J Cancer Res Clin Oncol; 1988; 114(4):347-58. PubMed ID: 3410875
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the conformational influences on the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes, II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-c omplexes.
Gust R; Schönenberger H
Arch Pharm (Weinheim); 1994 Dec; 327(12):763-9. PubMed ID: 7872853
[TBL] [Abstract][Full Text] [Related]
17. DNA-directed alkylating agents. 2. Synthesis and biological activity of platinum complexes linked to 9-anilinoacridine.
Palmer BD; Lee HH; Johnson P; Baguley BC; Wickham G; Wakelin LP; McFadyen WD; Denny WA
J Med Chem; 1990 Nov; 33(11):3008-14. PubMed ID: 2231598
[TBL] [Abstract][Full Text] [Related]
18. Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3.
Bernhardt G; Müller R; Gust R; Reile H; Keller C; Spruss T; Schönenberger H
Arch Pharm (Weinheim); 1992 Feb; 325(2):93-9. PubMed ID: 1605722
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, conformational studies, and investigations on the estrogen receptor binding of [R/S-1-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) complexes.
Gust R; Lubczyk V; Schmidt K; Shihada U
Arch Pharm (Weinheim); 2001 Mar; 334(3):93-100. PubMed ID: 11315340
[TBL] [Abstract][Full Text] [Related]
20. New platinum (II) and platinum (IV) complexes with 1,2-diaminocyclohexane. Synthesis and in vitro and in vivo antitumour evaluation.
Craciunescu DG; Furlani Candiani A; Scarcia V; Doadrio A; Ghirvu C
J Pharm Belg; 1985; 40(2):79-84. PubMed ID: 4009393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
